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To characterize the genomic context of New Delhi metallo-
b-lactamase-1 (NDM-1) and Klebsiella pneumoniae car-
bapenemase (KPC), we sequenced 78 Enterobacteriaceae 
isolates from Pakistan and the United States encoding 
KPC, NDM-1, or no carbapenemase. High similarities of the 
results indicate rapid spread of carbapenem resistance be-
tween strains, including globally disseminated pathogens.
Pathogenic Enterobacteriaceae, including Escherichia coli and Klebsiella pneumoniae, are major causes of 
multidrug-resistant (MDR) infections in hospitals world-
wide. These pathogens have recently been shown to have 
acquired resistance to carbapenems, and the US Centers 
for Disease Control and Prevention identified carbapen-
em-resistant Enterobacteriaceae as 1 of the 3 most urgent 
MDR threats (1). Among the Enterobacteriaceae, β-lactam 
resistance, including carbapenem resistance, is primarily 
caused by enzymatic degradation by β-lactamases. Two 
carbapenemase subclasses are especially problematic: 
Klebsiella pneumoniae carbapenemase (KPC) and New 
Delhi metallo-β-lactamase-1 (NDM-1). KPC, identified 
in 2001 (2), has become endemic to several noncontigu-
ous areas of the world, including the United States, Israel, 
Greece, South America, and China (3). NDM-1 was first 
described in 2008, although retrospective studies identified 
NDM-1 from 2006 (4) and is abundant in New Delhi water 
samples (5). Most patients from whom NDM-1 is isolated 
have an epidemiologic link to the Indian subcontinent, but 
NDM-1 has also recently become endemic to the Balkans 
and Middle East (6).
The spread of antibiotic resistance genes such as NDM-
1 and KPC is facilitated by horizontal gene transfer (HGT) 
between bacteria (7). Among globally disseminated patho-
gens, HGT facilitates combination of the most effective 
antibiotic resistance genes from diverse geographies into 
multidrug resistance plasmids that spread between strains. 
Recombination and transposition have created populations 
of these plasmids that have related architectures but vary in 
their composition of antibiotic drug resistance cassettes (8). 
This effect has enabled both KPC and NDM-1 to rapidly 
expand within the Enterobacteriaceae and other proteobac-
terial pathogens, such as Acinetobacter baumanii (9,10). 
Antibiotic resistance genes can also spread through clonal 
expansion in successful pathogenic strains, for example, 
KPC in K. pneumoniae sequence type (ST) 258 (11), and 
the extended-spectrum β-lactamase CTX-M-15 in E. coli 
ST131 (12). Both HGT and clonal expansion have enabled 
KPC and NDM-1 to rapidly spread to distant locations after 
their emergence (6,8). 
The similarities in the spread and resistance spectra 
of KPC and NDM-1 (both provide resistance to nearly all 
β-lactam antimicrobial drugs) leads to the hypothesis that 
similar mobile elements will make both genes available to 
similar pathogen populations. We tested this hypothesis 
by examining clinical Enterobacteriaceae isolates from 
Pakistan and the United States encoding NDM-1, KPC, or 
no carbapenemase.
The Study
We collected 450 bacterial isolates (including 195 Entero-
bacteriaceae) in Pakistan during February 2012–March 
2013 from Pakistan Railway General Hospital in Rawal-
pindi and the Pakistan Institute of Medical Sciences in Is-
lamabad. From this collection, we randomly selected 55 
Enterobacteriaceae isolates for whole-genome sequenc-
ing. We then selected 23 isolates from samples collected in 
the United States during January 2010–June 2013 from pa-
tients in Barnes Jewish Hospital in St. Louis, Missouri, that 
had similar proportions of β-lactam susceptibility and re-
sistance to the isolates collected in Pakistan for sequencing. 
All isolates were de-identified and retrieved from existing 
strain banks. The combined set included 33 E. coli, 30 K. 
pneumoniae, 9 Enterobacter cloacae, and 6 Enterobacter 
aerogenes (online Technical Appendix Table 1, http:// 
wwwnc.cdc.gov/EID/article/21/6/14-1504-Techapp1.
pdf). We extracted plasmid DNA from 9 isolates encod-
ing NDM-1, 11 isolates encoding KPC, and 3 isolates en-
coding CTX-M-15 and performed shotgun sequencing on 
those plasmid preparations. Detailed methods are described 
in the online Technical Appendix.
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KPC and NDM-1 in Enterobacteriaceae
Using antibiotic resistance gene predictions from the 
Resfams database (13) and core genome alignment, we 
constructed a phylogenetic tree for each species in our 
set, overlaid by the β-lactamases encoded by each isolate 
(Figure 1). Isolates from both locations were found to be 
members of the same subspecies clades (online Technical 
Appendix Figure 1) and to contain similar repertoires of 
β-lactamases (Figure 1), indicating that geography is not 
a discriminating variable for these isolates. Many of these 
isolates were also MDR: resistance to ciprofloxacin, trim-
ethoprim/sulfamethoxazole, gentamicin, doxycycline, and 
chloramphenicol occurred in 63%, 65%, 45%, 54%, and 
56% of isolates, respectively. As expected from results of 
previous work (8), E. coli ST131 isolates had high rates of 
CTX-M carriage (82%; Figure 1, panel A) and ciprofloxa-
cin resistance (100%).
The variety of strains that we discovered encoding KPC 
and NDM-1 is consistent with existing evidence that HGT is 
a major factor in their spread. All KPC genes were proximal 
to Tn4401 and all NDM-1 genes were carried on ISAba125, 
mobile elements with which each gene has respectively been 
previously associated (14). We observed multiple examples 
of NDM-1 within the K. pneumoniae ST11 clade (15) (Fig-
ure 1, panel B; online Technical Appendix Figure 1, panel 
B), a close relative of ST258. This association could be 
caused by clonal expansion or multiple HGT events and em-
phasizes that lineages known to encode KPC are now also 
acquiring NDM-1. We also observed high rates of NDM-1 
carriage in Enterobacter isolates (Figure 1, panels C and D), 
which in general showed a high number (maximum 8) and 
wide variety of β-lactamases. These isolates were also MDR: 
57% of the Enterobacter isolates were resistant to all or all 
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Scale bars indicate nucleotide substitutions per site.
DISPATCHES
but 1 of the antimicrobial drugs tested. At best, these Entero-
bacter strains are a reservoir for resistance in Pakistan; at 
worst, they are the vanguard of an expansion of carbapenem-
resistant Enterobacter infections.
Previous observations have predominantly found 
KPC and NDM-1 to be expressed from plasmids (6,11). 
To characterize the sequence similarity of plasmids 
within the NDM- and KPC-carrying plasmid popula-
tions, we purified and sequenced plasmid DNA from 9 
isolates encoding NDM-1, 11 encoding KPC, and 3 en-
coding CTX-M-15. Sequencing showed that these plas-
mids include representatives from IncHI2, IncY, IncN, 
IncFIA, IncFIB, IncFIC, and IncI1 incompatibility 
groups. Using reciprocal BLAST (http://blast.ncbi.nlm.
nih.gov/Blast.cgi) alignment between each pair of plas-
mid preparations, we calculated the percentage of each 
plasmid shared using a 99% identity threshold. We per-
formed this same analysis for all sequenced plasmids 
containing NDM-1, KPC, or CTX-M available in the 
National Center for Biotechnology Information data-
base (http://www.ncbi.nlm.nih.gov) together with our set 
(Figure 2) and separately (online Technical Appendix 
Figure 2). Certain components, primarily mobile ele-
ments, were abundant within these plasmids: the aver-
age plasmid shared 500 contiguous bases with 58 of the 
other plasmids; however, median BLAST identity for 
this pairwise comparison was <12%, even when consider-
ing plasmids with the same β-lactamase, suggesting that 
both carbapenemases exist within a variety of plasmid 
configurations.
To visualize this comparison of carbapenemase plas-
mids, we generated a network diagram in which each node 
represented a plasmid and each line represented shared se-
quence between 2 plasmids (Figure 2, panel B). Node size 
and line width correlate to the number of nucleotides con-
tained in the plasmid or sharing interaction. This visualiza-
tion shows the abundant small, shared regions that exist be-
tween most plasmid pairs, represented as thin background 
lines. This visualization also highlights the larger shared 
regions that indicate highly similar plasmids, represented 
by the few wide lines. These outliers were often between 
pairs of plasmids encoding the same β-lactamase but were 
also observed between NDM-1 and KPC containing plas-
mids (maximum 79% of smaller plasmid length).
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Conclusions
Together, this evidence supports our hypothesis that strains 
and plasmids known to carry either carbapenemase also have 
access to the other. Given the similarity of carbapenemase-
negative strains to those carrying KPC or NDM-1 and the 
high diversity of plasmids in which they can be found, we 
anticipate that global carbapenem usage will encourage HGT 
of both of these carbapenemases into additional strain and 
plasmid backgrounds. Because KPC and NDM-1 are poised 
to cross genetic and geographic boundaries, we recommend 
that hospitals routinely screen Enterobacteriaceae strains for 
both genes, even in regions where they are not yet endemic. 
We further advocate reduced carbapenem use to limit the se-
lection for resistance against this vital antibiotic class.
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KPC and NDM-1 Genes in Related 
Enterobacteriaceae Strains and Plasmids 
from Pakistan and the United States 
Technical Appendix 
Methods and Materials 
Sample Selection, Processing, and Phenotyping 
We collected 450 Pakistani bacterial isolates (PH) initially recovered from de-identified 
clinical samples from urinary, blood stream, genitourinary, and wound infections collected 
between February 2012 and March 2013 at Pakistan Railway General Hospital, Rawalpindi, 
Pakistan, and the Pakistan Institute of Medical Sciences in Islamabad, Pakistan. These included 
all ESKAPE pathogen isolates available in the Pakistani hospital strain banks during the 
indicated collection period. From these 450 isolates, we chose a random subset of 55 isolates 
from the Enterobacteriaceae family (from a total of 195 Enterobacteriaceae in this collection) 
for phenotypic and genotypic analysis. We also selected 48 US Enterobacteriaceae isolates 
(WU) from banked, de-identified frozen stocks of Escherichia coli, Klebsiella pneumoniae, and 
Enterobacter cloacae at Barnes Jewish Hospital/Washington University School of Medicine in 
Saint Louis, Missouri, United States to have beta-lactam resistance and susceptibility phenotypes 
in similar proportions to the Pakistani Enterobacteriaceae isolates, with a particular focus on the 
meropenem resistance phenotype (protocols for growth and phenotyping are described below). 
The WU strains were originally isolated from urine, respiratory, bone, and bile specimens 
between January 2010 and June 2013. Of the 48 WU isolates, 23 isolates were chosen for 
genome sequencing to generally match the species distribution of the 55 PH isolates as well as 
their beta-lactam resistance profiles, with the exception of Enterobacter aerogenes, for which 
none were available in the WU collection. In total, 33 Escherichia coli (24 PH, 9 WU), 30 
Klebsiella pneumoniae (19 PH, 11 WU), 9 Enterobacter cloacae (6 PH, 3 WU), and 6 
Enterobacter aerogenes (all 6 PH) isolates were included for the whole genome sequencing 
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analysis (Technical Appendix Tables 1 and 2).  We cultivated all isolates on MacConkey and 
sheep’s blood agar (Hardy Diagnostics). We then grew single colonies in LB broth liquid culture 
for DNA extraction. We assessed each isolate for susceptibility to ampicillin, cefazolin, 
cefotetan, ceftazidime, ceftriaxone, cefepime, meropenem, ciprofloxacin, trimethoprim-
sulfamethoxazole, gentamicin, doxycycline, and chloramphenicol by Kirby-Bauer disk diffusion 
according to Clinical and Laboratory Standards Institute guidelines and interpretive criteria (1). 
Prior to whole genome sequencing, the species identity of PH and WU isolates was determined 
with VITEK MS MALDI-TOF MS v2.0 knowledgebase (bioMerieux) as previously described 
(2,3). We then extracted total DNA using the Invitrogen Charge Switch gDNA Mini Bacteria kit 
per the manufacturer’s protocol. We also extracted plasmid DNA from 11 KPC and 9 NDM-1 
encoding isolates (as well as 3 CTX-M-15 encoding isolates), as determined by PCR and the 
genome sequencing, using the Qiagen Large Construct kit per the manufacturer’s protocol. We 
included one non- Enterobacteriaceae plasmid preparation from an Acinetobacter baumannii 
isolate (PH), which had been identified to contain NDM-1 by PCR. 
Illumina Library Preparation 
We sheared 500ng of total DNA from each isolate to ~300 bp fragments fragments in 
nine rounds of shearing of ten minutes each on the BioRupter XL. In each round the power 
setting was ‘H’ and samples were treated for 30s and allowed to rest for 30s. Each sample was 
concentrated using the Qiagen MinElute PCR purification kit per the manufacturer’s protocol. 
End Repair of the sheared DNA fragments was initiated with the addition of 2.5 µl of T4 DNA 
ligase buffer with 10mM ATP (NEB, B0202S), 1 µl of 1 mM dNTPs (NEB), 0.5 µl T4 
Polymerase (NEB, M0203S), 0.5 µl T4 PNK (NEB M0201S), and 0.5 µl Taq Polymerase (NEB, 
M0267S). This mixture was incubated at 25°C for 30 min, then at 75°C for 20 min. Barcoded 
adapters were then added to the solution along with 0.8µl of T4 DNA ligase (NEB, M0202M), 
for the purpose of ligating the adapters to the DNA fragments. This solution was then incubated 
at 16ºC for 40min, then 65°C for 10min. At this point the adapter-ligated DNA was purified 
using the Qiagen MinElute PCR purification kit per the manufacturer’s protocol. 
The DNA fragments were then size selected on a 2% agarose gel in 1X TBE buffer 
stained with Biotium GelGreen dye (Biotium). DNA fragments were combined with 2.5uL 6X 
Orange loading dye before loading on to the gel. Adaptor-ligated DNA was extracted from gel 
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slices corresponding to DNA of 250-300bp using a QIAGEN MinElute Gel Extraction kit per the 
manufacturer’s protocol. The purified DNA was enriched by PCR using 12.5µL 2X Phusion HF 
Master Mix and 1µL of 10µM Illumina PCR Primer Mix in a 25µL reaction using 1µL of 
purified DNA as template. DNA was amplified at 98°C for 30 seconds followed by 18 cycles of 
98°C for 10 seconds, 65°C for 30 seconds, 72°C for 30 seconds with a final extension of 5min. at 
72°C. Afterwards, the DNA concentration was measured using the Qubit fluorometer and 
10nmol of each sample (up 106 per lane of sequencing) were pooled. Subsequently, samples 
were submitted for Illumina HiSeq-2500 Pair-End (PE) 101bp sequencing at GTAC (Genome 
Technology Access Center, Washington University in St. Louis) at 9pmol per lane. 
Genome Sequence Assembly 
All sequencing reads were de-multiplexed by barcode into separate genome bins. Reads 
were quality trimmed to remove adapter sequence and bases on either end with a quality score 
below 19. Any reads shorter than 31bp after quality trimming were not used in further analysis. 
The best reference sequence was chosen for each isolate or plasmid by mapping 10000 reads 
chosen randomly from that isolate against all reference genomes (from NCBI Genome, 
downloaded July 14th 2014) of the same species as the isolate (in the case of genomic DNA 
assembly) or against all plasmid sequences containing NDM-1, KPC, or CTX-M (in the case of 
plasmid DNA assembly). Reads were mapped using Bowtie 2 (4) (command: bowtie2 –x 
<reference_genome_index_name> -1 <forward_read_file> -2 <reverse_read_file> -q --phred33 -
-very-fast –I 100 –X 600 --no-discordant --no-mixed --no-unal --no-hd --no-sq --omit-sec-
strand). The genome or plasmid against which the highest percentage of reads mapped was used 
as the reference sequence for that assembly. It was empirically determined that if this first 
mapping included fewer than 60% of the reads, then the assembly would be best done 
completely de novo. For isolates with >60% of reads matching a reference sequence, all reads 
were mapped to that sequence (command: bowtie2 –x <reference_genome_index_name> -1 
<forward_read_file> -2 <reverse_read_file> -q --phred33 --very-sensitive-local -I 200 -X 1000 -
S <sam_output>). Variants from the reference were called using samtools (commands: samtools 
view -buS <sam_file> | samtools sort -m 4000000000 - <sample_prefix> ### samtools index 
<bam_file> ### samtools mpileup -uD -f <reference_genome> <bam_file> | bcftools view -bcv - 
> <bcf_file> ### bcftools view <bcf_file>). The variant call format file was then filtered to 
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remove SNPs with a quality score lower than 70 or coverage greater than twice the average 
coverage expected per base. Custom scripts were then used to extract DNA sequences from the 
reference genome with > three independent reads, to create a fragment file of regions in the 
sample genome matching the reference genome modified with high-quality variant information. 
De novo assembly of the reads from each isolate was completed using Velvet (5) 
(commands: velveth <output_directory> 51 -fastq -shortPaired <interleaved_reads> ### velvetg 
<output_directory> -ins_length 400 -exp_cov <kmer_coverage>  -cov_cutoff 
<coverage_cutoff>). Kmer coverage was calculated as: total read coverage*0.50 (because the 
kmer length was approximately half the read length), and the coverage cutoff was calculated as 
the kmer coverage divided by eight. If a complete reference mapping was performed, then 
contigs from the de novo assembly and reference mapping were put in an additional velvet 
assembly step as long reads with the original reads files (commands: velveth <output_directory> 
51 -fastq -shortPaired -separate <forward_reads> <reverse_reads> -fasta -long 
<de_novo_fragments> <reference_fragments> ### velvetg <output_directory> -ins_length 400 -
clean yes -conserveLong yes -exp_cov <kmer_coverage> -cov_cutoff <coverage_cutoff> -
scaffolding yes -long_mult_cutoff 0). Finally all fragments were collapsed on nucleotide identity 
using cd-hit (command: cd-hit-est -I <fragment_file> -o <collapsed_file> -d 0 -M 0). All 
fragments smaller than 500bp were partitioned to a separate file by a custom script. Plasmid 
sequences were assembled by this same method, with the sequences of all complete plasmids 
encoding, NDM-1, KPC, or CTX-M used as references. 
ORF Prediction and Annotation 
ORF prediction for each genome was performed separately using GeneMark (6) models 
based on the closest reference genome (command: gmhmmp -m <model_name> -o <outfile> -a 
<contig_name_file>). Each ORF was compared to three databases of profile hidden Markov 
models using HMMR (7): Pfam (command: hmmscan --cut_ga -o /dev/null --tblast 
<target_out_file> --domtblast <domain_out_file> <Pfam_database_file> <protein_input_file>), 
TIGRFAMs (command: hmmscan --cut_ga -o /dev/null --tblast <target_out_file> --domtblast 
<domain_out_file> <database_file> <protein_input_file>), and Resfams 
(dantaslab.wustl.edu/resfams/) (8) (command: hmmscan --cut_ga -o /dev/null --tblast 
<target_out_file> --domtblast <domain_out_file> <database_file> <protein_input_file>). All 
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functional annotations were concatenated into a single file by a custom script. 756 E. coli and 54 
K. pneumoniae completed and draft genomes were downloaded from the National Center for 
Biotechnology Information (NCBI) on April 15th 2014, for the purpose of comparing to the 
isolate set. GeneMark models from the completed genomes were used to predict ORFs for those 
genomes, while for draft genomes models created from E. coli K12 MG1655 (for E. coli draft 
genomes) or K. pneumoniae KCTC 2242 (for K. pneumoniae draft genomes) were used for ORF 
prediction. All genome and plasmid sequences were deposited into NCBI (BioProject accession 
number: PRJNA261540). 
In silico MLST  
Multi-Locus Sequence Typing (MLST) profiles were downloaded from PubMLST 
(pubmlst.org). When an absolute MLST profile could not be identified for an organism (because 
of ambiguous bases or incomplete assembly of one or more loci) the remaining possible 
sequence types (ST) based on the incomplete information were identified. In all cases a strain 
could be identified as one of at most 19 ST using this methodology. MLST profiles were only 
applied to Escherichia coli and Klebsiella pneumoniae since the PubMLST database does not 
contain an Enterobacter table. 
Core Genome Alignment 
Command for whole genome alignment using mugsy (9): command: mugsy --directory 
<output_directory> --prefix <output_prefix> <genome_fasta_1> <genome_fasta_2> … 
<genome_fasta_N>. For E. coli, K. pneumoniae, and E. cloacae a single reference genome was 
included in the alignment to provide context (E. coli K12 MG1655, K. pneumonaie KCTC 2242, 
and E. cloacae ATCC 13047 respectively). Poorly aligned regions (i.e. plasmids or recombined 
regions, which could create noise in the phylogenetic signal) were removed using Gblocks (10) 
(command: Gblocks <input_file> -t=d -b3=24) leaving only the core genome alignment. 
Maximum likelihood trees made made by RaxML (11) (command: raxmlHPC-SSE3 -s 
<input_file> -n <output_file> -m GTRGAMMA -d -f a -N 100 -x 54321 -w <output_directory>) 
and FastTree (12) (command: FastTree -gtr -nt -gamma -nome <input_file> > <output_file>) 
were compared for agreement. When trees made by both methods were in agreement, the output 
from FastTree was used for visualization. Files were converted between various required formats 
by custom scripts. 
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Subspecies clades were defined as groups of branches descended from a common 
ancestor where no individual branch within the clade could have more than 0.005 substitutions 
per site. This definition yielded the same groupings as the in silico MLST described above, in all 
cases where all members of a clade could be assigned to a known ST (online Technical 
Appendix Figure 1, panels A,B). 
Specific β-lactamase Identification 
A BLAST database was constructed from the amino acid sequences of all β-lactamases 
cataloged in the Bush and Jacoby (13) database at www.lahey.org/Studies/ (accessed March 25th, 
2014). Genes from our genomes annotated as β-lactamases were extracted and compared against 
this database by BLAST. Exact matches were then re-annotated with their specific β-lactamase 
name, while inexact matches were recorded as their closest hit plus an asterisk. 
Plasmid Comparisons 
We compared plasmid sequences by an all-against-all pairwise nucleotide BLAST 
alignment. For each pair of plasmids, we calculated the percentage of each plasmid that aligned 
at >99% identity. We then binned the percentages from each pairwise alignment into groups 
based on the defining β-lactamase of their query and subject plasmids. We also generated 
network diagrams from the pairwise BLASTs using custom Python scripts and Cytoscape (14), 
only including regions above 99% identity and over 500 bp. 
Isolate Characteristics 
The sampled Enterobacteriaceae isolates are phylogenetically diverse and include 
multiple examples of known pathogenic sequence types. We performed WGS of each isolate, 
totaling 33 Escherichia coli isolates, 30 Klebsiella pneumoniae isolates, 9 Enterobacter cloacae 
complex isolates, and 6 Enterobacter aerogenes isolates. We then used whole genome alignment 
of the core genomes of each species to reconstruct the phylogenetic relationships of each isolate 
at high resolution (Technical Appendix Figure 2). The species trees demonstrate that we sampled 
genomes from a variety of evolutionary clades as well as from multiple members of specific 
clades. They also demonstrate that clades could include isolates from both the United States and 
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Pakistan, allowing us to ignore the geographic variable and group the isolates by carbapenemase 
carriage for subsequent analyses. We also used housekeeping gene sequence from each isolate to 
perform in silico MLST, allowing us to compare our phylogenetic analysis to previously 
identified sequence types. We found that the clades on our tree include globally-disseminated 
pathogen sequence types, such as ST131 in E. coli and ST11 (single locus variant of ST258) in 
K. pneumoniae. 
ST131 is noted for its virulence as well as for its frequent association with the CTX-M β-
lactamases and fluoroquinolone resistance (15–17). Previous reports have found ST258, and 
closely related K. pneumoniae, to have relatively high rates of carbapenemase carriage (18,19). 
Despite the utility of MLST-based classification for large-scale epidemiological purposes, 
binning clinical isolates into sequence types masks genotypic and phenotypic variation due to 
HGT or single nucleotide polymorphisms, and therefore MLST cannot be used for fine-grained 
epidemiology or as an accurate predictor of antibiotic susceptibility. For example, two previous 
studies have shown that ST131 can be subdivided into three distinct lineages with different rates 
of antibiotic resistance (15,16). One of these studies found that the rapid global expansion of 
ST131 has been driven by the success of a specific subclone of ST131 that encodes 
fluoroquinolone resistant gyrA and parC alleles and CTX-M-15 (16), a characterization which 
fits 7 of  our 11 ST131 isolates. We also identified a single ST131 isolate carrying KPC-2, which 
was resistant to all β-lactams tested. We also observed K. pneumoniae ST11 isolates carrying 
KPC-3, and others carrying NDM-1, which fits with reports characterizing ST11 as being highly 
common worldwide and frequently encoding carbapenemases (18,19). 
Antibiotic Resistance Phenotypes 
To establish the overall susceptibility profiles of each of our strains, we performed 
phenotypic tests using Kirby Bauer Disk diffusion in accordance with CLSI guidelines on all 78 
clinical isolates against 12 antibiotics including 7 β-lactams (Technical Appendix Table 1). We 
found that 63% of all isolates were resistant to ciprofloxacin, a fluoroquinolone commonly used 
to treat urinary tract infections. We also found resistance to trimethoprim-sulfamethoxazole in 
65% of isolates, and gentamicin, doxycycline, and chloramphenicol exhibited in vitro resistance 
in 45%, 54%, and 56% of isolates, respectively. In the β-lactams, we saw near universal 
resistance to ampicillin (96% of isolates) and variable resistance to the cephalosporins. A high 
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rate of resistance to meropenem was observed (31% of isolates), but this finding was not 
surprising since this was the property on which many of the isolates had been selected. 
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Technical Appendix Figure 1. Phylogenetic trees for isolates from samples collected in Pakistan and the 
United States. Trees are separated by species, A) Escherichia coli, B) Klebsiella pneumoniae, C) 
Enterobacter cloacae, and D) Enterobacter aerogenes, but not rooted. Bootstrap values are 1 for each 
branch unless otherwise noted. For each species ≈50% of the genome was determined to be core, and 
was used for phylogenetic inference. Scale bars indicate the nucleotide substitutions per site. In a) and b) 
sequence types (ST) as determined by in silico multilocus sequence typing are indicated by boxes 
grouping members of the same ST together. Unk = ST does not correspond to any reported in pubMLST, 
Ind = exact ST could not be determined due to sequencing error. Reference genomes included for E. coli 
(K12 MG1655), K. pneumoniae (KCTC 2242), and E. cloacae (ATCC 13047) on their respective trees. 
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Technical Appendix Figure 2. Sequence conservation between plasmids containing NDM-1, KPC, or 
CTX-M β-lactamases. All plasmids from A) NCBI and B) this study that contained a NDM-1, KPC, or CTX-
M β-lactamase were analyzed by all-against-all BLAST. Plasmid interactions were defined by the 
percentage of the query plasmid conserved (at >99% identity) in the subject plasmid. Plasmid interactions 
were plotted based on the defining β-lactamase of their query and subject plasmids. 
 
Technical Appendix Table 1. Antibiotic drug susceptibility profiles of clinical isolates from Pakistan and the United States* 
Species, no. Location Phenotype AM CZ CTT CAZ CRO FEP MEM CIP SXT GM D† C† 
E. coli, 9 U.S.A R 78% 67% 22% 44% 44% 44% 44% 56% 33% 22% 33% 33% 
I 0% 11% 22% 0% 0% 0% 0% 0% 0% 0% 0% 11% 
S 22% 22% 56% 56% 56% 56% 56% 44% 67% 78% 11% 0% 
E. coli, 24 Pakistan R 96% 83% 13% 38% 63% 21% 0% 67% 75% 38% 67% 33% 
I 4% 17% 0% 13% 0% 21% 0% 0% 0% 0% 17% 4% 
S 0% 0% 88% 50% 38% 58% 100% 33% 25% 63% 17% 63% 
K. pneumoniae, 
11 
U.S.A R 100% 36% 0% 36% 36% 36% 36% 27% 36% 9% 18% 27% 
I 0% 0% 36% 0% 0% 0% 0% 0% 9% 0% 0% 0% 
S 0% 64% 64% 64% 64% 64% 64% 73% 55% 91% 18% 9% 
K. pneumoniae, 
19 
Pakistan R 100% 68% 21% 63% 63% 42% 16% 63% 68% 58% 32% 58% 
I 0% 5% 0% 0% 0% 16% 0% 11% 5% 0% 21% 11% 
S 0% 26% 79% 37% 37% 42% 84% 26% 26% 42% 47% 32% 
E. cloacae, 3 U.S.A R 100% 100% 100% 100% 100% 100% 100% 67% 67% 33% 33% 33% 
I 0% 0% 0% 0% 0% 0% 0% 0% 0% 33% 33% 33% 
S 0% 0% 0% 0% 0% 0% 0% 33% 33% 33% 33% 33% 
E. cloacae, 6 Pakistan R 83% 100% 67% 100% 100% 83% 67% 83% 83% 100% 50% 83% 
I 0% 0% 0% 0% 0% 17% 0% 17% 0% 0% 17% 0% 
S 0% 0% 33% 0% 0% 0% 33% 0% 17% 0% 33% 17% 
E. aerogenes, 6 Pakistan R 100% 100% 17% 100% 100% 100% 100% 100% 100% 67% 83% 100% 
I 0% 0% 83% 0% 0% 0% 0% 0% 0% 0% 17% 0% 
S 0% 0% 0% 0% 0% 0% 0% 0% 0% 33% 0% 0% 
*AM, ampicillin; CZ, cefazolin; CTT, cefotetan; CAZ, ceftazidime; CRO, ceftriaxone;FEP, cefepime; MEM, meropenem; CIP,  
ciprofloxacin; SXT,  trimethoprim-sulfamethoxazole; GM ,  gentamicin; D, doxycycline; C, chloramphenicol; R, Resistant; I, 
Intermediate; S, Susceptible. 
†For USA E.coli and K. pneumoniae in doxycycline and chloramphenicol selections, n=4.  
 
 
Publisher: CDC; Journal: Emerging Infectious Diseases 
Article Type: Dispatch; Volume: 21; Issue: 6; Year: 2015; Article ID: 14-1504 
DOI: 10.3201/eid2106.141504; TOC Head: Dispatch 
Page 12 of 13 
Technical Appendix Table 2. Assembly metrics for whole genome assemblies 
Species Genome Number of contigs N50 Largest contig Total nucleotides 
Escherichia coli PH100 1288 35053 385222 6309191 
Escherichia coli PH101–2 404 31119 177520 4857948 
Escherichia coli PH105 288 55979 220618 5045926 
Escherichia coli PH108 754 12427 95430 4930975 
Escherichia coli PH114 280 68389 450011 5902296 
Escherichia coli PH118 1028 13550 93913 5073129 
Escherichia coli PH129 235 76630 188170 5470109 
Escherichia coli PH135 156 87914 545356 4864787 
Escherichia coli PH141 656 14806 87255 4469903 
Escherichia coli PH143 355 33581 145252 4875919 
Escherichia coli PH151–2 368 41647 143184 5066089 
Escherichia coli PH156–1 720 24256 203811 5434228 
Escherichia coli PH18 357 39599 126851 5026978 
Escherichia coli PH20 513 20802 122933 4967604 
Escherichia coli PH31 394 40363 219779 5077941 
Escherichia coli PH39 465 28063 96484 4695860 
Escherichia coli PH51 1108 13989 85055 4988648 
Escherichia coli PH5 193 185476 496282 5367128 
Escherichia coli PH85 331 45973 149681 5118463 
Escherichia coli PH90 475 31325 258054 5169559 
Escherichia coli PH92–1 738 19526 90560 5313215 
Escherichia coli PH93 487 31876 685039 5927902 
Escherichia coli PH94 325 40628 218502 4960477 
Escherichia coli PH98 401 28050 272240 4791597 
Escherichia coli WU31 502 21374 148889 4858305 
Escherichia coli WU32 329 43395 166954 5598148 
Escherichia coli WU33 487 25419 139243 4975544 
Escherichia coli WU34 278 67976 229510 5206081 
Escherichia coli WU35 267 51428 235055 4846364 
Escherichia coli WU40 145 202444 388283 5052711 
Escherichia coli WU43 193 91836 346403 5033909 
Escherichia coli WU44 196 92332 610815 5473063 
Escherichia coli WU45 332 40224 155439 4990710 
Klebsiella pneumoniae PH102 2205 3247 29455 4976237 
Klebsiella pneumoniae PH10 192 129071 506496 5877659 
Klebsiella pneumoniae PH11 224 109166 648719 5657202 
Klebsiella pneumoniae PH124 238 66778 202869 5515528 
Klebsiella pneumoniae PH12 317 46831 180775 5530414 
Klebsiella pneumoniae PH139 263 92250 433917 5458209 
Klebsiella pneumoniae PH150–2 487 40719 311295 5568393 
Klebsiella pneumoniae PH152 354 74725 275992 5863335 
Klebsiella pneumoniae PH24–1 181 209112 601209 5541053 
Klebsiella pneumoniae PH25 439 51744 186984 5437740 
Klebsiella pneumoniae PH28–1 302 72750 480318 5876774 
Klebsiella pneumoniae PH38–1 178 243482 614325 6135768 
Klebsiella pneumoniae PH40 471 43868 232550 6212797 
Klebsiella pneumoniae PH44 251 133296 479093 6297207 
Klebsiella pneumoniae PH49–2 273 84383 550379 6883299 
Klebsiella pneumoniae PH72 2195 13163 144014 7250407 
Klebsiella pneumoniae PH73 997 11652 91567 5804995 
Klebsiella pneumoniae PH88 150 289170 512144 5630043 
Klebsiella pneumoniae PH9 927 12231 72933 5207334 
Klebsiella pneumoniae WU10 179 117943 480943 5928719 
Klebsiella pneumoniae WU12 1131 12084 59345 5227362 
Klebsiella pneumoniae WU18 961 14636 96067 5664085 
Klebsiella pneumoniae WU21 372 67952 249904 5556247 
Klebsiella pneumoniae WU23 142 208533 460529 5958526 
Klebsiella pneumoniae WU2 407 55286 345910 6330941 
Klebsiella pneumoniae WU3 705 94321 408241 6853166 
Klebsiella pneumoniae WU6 297 104936 426673 5919869 
Klebsiella pneumoniae WU7 227 79691 298601 5818526 
Klebsiella pneumoniae WU8 377 64077 729491 7506385 
Klebsiella pneumoniae WU9 141 120728 292977 5557123 
Enterobacter aerogenes 112–2 90 177700 566534 5153448 
Enterobacter aerogenes PH113 450 22178 97515 4695038 
Enterobacter aerogenes PH134 274 107942 399309 5126469 
Enterobacter aerogenes PH138 776 30613 144769 9901518 
Publisher: CDC; Journal: Emerging Infectious Diseases 
Article Type: Dispatch; Volume: 21; Issue: 6; Year: 2015; Article ID: 14-1504 
DOI: 10.3201/eid2106.141504; TOC Head: Dispatch 
Page 13 of 13 
Species Genome Number of contigs N50 Largest contig Total nucleotides 
Enterobacter aerogenes PH63 225 47345 184904 5211429 
Enterobacter aerogenes PH84–2 226 61644 336177 5307861 
Enterobacter cloacae PH23 179 83227 473778 5536166 
Enterobacter cloacae PH24–2 1238 20166 178617 8756501 
Enterobacter cloacae PH112–1 621 175912 517857 9155709 
Enterobacter cloacae PH125 1221 45282 215620 6004095 
Enterobacter cloacae PH158 552 34922 172567 9711730 
Enterobacter cloacae PH82 389 29307 134776 4974173 
Enterobacter cloacae WU26 538 46418 208322 5369428 
Enterobacter cloacae WU27 315 45300 155565 5251409 
Enterobacter cloacae WU29 457 24686 86433 4888311 
Average NA 490 67666 285311 5664479 
 
Technical Appendix Table 3. Assembly metrics for plasmid assemblies 
Species Genome Number of contigs N50 Largest contig Total nucleotides 
Acinetobacter baumannii PH147_2 98 3072 7683 181370 
Escherichia coli WU31 41 16473 48183 214615 
Escherichia coli WU32 86 11069 31992 233185 
Escherichia coli WU33 87 9555 47149 168182 
Klebsiella pneumoniae PH11 53 19073 48703 230288 
Klebsiella pneumoniae PH88 39 15980 48463 218205 
Klebsiella pneumoniae WU13 6 12943 12943 18694 
Klebsiella pneumoniae WU14 4 12976 12976 18501 
Klebsiella pneumoniae WU17 374 4432 60538 328889 
Klebsiella pneumoniae WU18 40 18017 43330 221015 
Klebsiella pneumoniae WU19 37 22152 87768 315122 
Enterobacter aerogenes PH112_2 80 19156 52826 450788 
Enterobacter aerogenes PH113 17 5703 19905 59909 
Enterobacter aerogenes PH134 22 4168 9715 48836 
Enterobacter aerogenes PH138 171 8795 35183 466555 
Enterobacter aerogenes PH63 37 29896 44891 282470 
Enterobacter cloacae PH23 111 12334 42017 516173 
Enterobacter cloacae PH24_2 95 15201 41616 562271 
Enterobacter cloacae PH82 206 9384 37900 641720 
Average NA 84 13178 38620 272463 
 
 
 
